Muscarinic receptors in the mammalian heart

Pharmacological Research

Volumn 44, Issue 3, 2001, Pages 161-182

  Dhein, Stefan ^a   Van Koppen, Chris J ^b   Brodde, Otto Erich ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Acetylcholine; Age; Heart; Heart disease; Muscarinic cholinoceptors

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; 4 FLUORO HEXAHYDRO SILADIFENIDOL; ACETYLCHOLINE; ATROPINE; CALCIUM; CARBACHOL; DARIFENACIN; G PROTEIN COUPLED RECEPTOR; HIMBACINE; METHOCTRAMINE; MT 3; MT 7; MUSCARINIC AGENT; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; N [2 [2 (DIPROPYLAMINOMETHYL) 1 PIPERIDYL]ETHYL] 5,11 DIHYDRO 6 OXO 6H PYRIDO[2,3 B][1,4]BENZODIAZEPINE 11 CARBOXAMIDE; OTENZEPAD; PHOSPHOTRANSFERASE; PIRENZEPINE; POTASSIUM CHANNEL; RECEPTOR SUBTYPE; TROPICAMIDE; UNCLASSIFIED DRUG;

AGE; ANATOMY; ATRIOVENTRICULAR CONDUCTION; AUTONOMIC NERVOUS SYSTEM; CALCIUM CELL LEVEL; CALCIUM CURRENT; CELL COMMUNICATION; CORONARY BLOOD VESSEL; HEART; HEART FAILURE; HEART MUSCLE CONTRACTILE FORCE; HUMAN; ION CURRENT; KNOCKOUT GENE; NONHUMAN; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; PROTEIN STRUCTURE; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; SINUS NODE; SPECIES DIFFERENCE; VAGUS NERVE STIMULATION;

EID: 0034828326     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.2001.0835     Document Type: Article

References (308)

1. The parasympathetic neuroeffector junction of the heart
2. Regulation of cardiac ion channels by catecholamines, acetylcholine and second messenger systems
3. Parasympathetic control of cardiac electrical activity
4. The pharmacology of flaxedil with observations on certain analogs
5. A comparison of affinity constants for muscarine-sensitive acetylcholine receptors in guinea pig atrial pacemaker cells at 29°C and in ileum at 29°C and 37°C
6. Pirenzepine distinguishes between subclasses of muscarinic receptors
7. Antagonist discrimination between ganglionic and ileal muscarinic receptors
8. Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization
9. Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor
10. Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from the cDNA sequence
11. Identification of a family of muscarinic acetylcholine receptor genes
12. Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes
13. Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors
14. Muscarinic receptor subtypes
15. Muscarinic receptors: Characterization, coupling and function
16. International union of pharmacology. XVII. Classification of muscarinic acetylcholine receptors
17. Adrenergic and muscarinic receptors in the human heart
18. Chromosomal mapping of the five human genes encoding muscarinic acetylcholine receptors
19. Receptor subtypes or species homologues: Relevance to drug discovery
20. Muscarinic acetylcholine receptors: Peptide sequencing identifies residues involved in antagonist binding and disulfide bond formation
21. Site-directed mutagenesis of the rat m1 muscarinic acetylcholine receptor: Role of conserved cysteines in receptor function
22. Propylbenzilylcholine mustard labels an acidic residue in transmembrane helix 3 of the muscarinic receptor
23. Acetylcholine mustard labels the binding site aspartate in muscarinic acetylcholine receptors
24. Site-directed mutagenesis of the m2 muscarinic acetylcholine receptor: Analysis of the role of N-glycosylation in receptor expression and function
25. Structural basis of receptor/G-protein coupling selectivity studied with muscarinic receptors as model systems
26. Molecular basis of muscarinic receptor function
27. Molecular biology of muscarinic acetylchollne receptors
28. Muscarinic acetylcholine receptors: Signal transduction through multiple effectors
29. An M2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover
30. 2 muscarinic receptor
31. Desensitization of G protein-coupled receptors in the cardiovascular system
32. Therapeutic potential of G-protein coupled receptor kinases in the heart
33. Phosphorylation and desensitization of human m2 muscarinic cholinergic receptors by two isoforms of the beta-adrenergic receptor kinase
34. Sequestration of muscarinic acetylcholine receptor m2 subtypes. Facilitation by G protein-coupled receptor kinase (GRK2) and attenuation by a dominant-negative mutant of GRK2
35. Phosphorylation of human m1 muscarinic acetylcholine receptors by G protein-coupled receptor kinase 2 and protein kinase C
36. Activation by G protein beta gamma subunits of agonist- or light-dependent phosphorylation of muscarinic acetylcholine receptors and rhodopsin
37. Expression, purification and characterization of the G protein-coupled receptor kinase GRK6
38. Altered airway and cardiac responses in mice lacking G protein-coupled receptor kinase 3
39. Muscarinic supersensitivity and impaired receptor desensitization in G-protein-coupled receptor kinases 5-deficient mice
40. Synergistic regulation of m2 muscarinic acetylcholine receptor desensitization and sequestration by G protein-coupled receptor kinase-2 and beta-arrestin-1
41. Desensitization and internalization of the m2 muscarinic acetylcholine receptor are directed by independent mechanisms
42. Regulation of muscarinic acetylcholine receptor sequestration and function by β-arrestin
43. Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling
44. Intracellular trafficking of the muscarinic acetylcholine receptor: Importance of subtype and cell type
45. Involvement of receptor cycling and receptor reserve in resensitization of muscarinic responses in SH-SY5Y human neuroblastoma cells
46. Rapid desensitization of muscarinic m3 receptor-stimulated polyphosphoinositide responses
47. 2 muscarinic acetylcholine receptors confers selective and long-lasting desensitization of signaling to phospholipase C
48. Receptor internalization delays m4 muscarinic acetylcholine receptor resensitization at the plasma membrane
49. Desensitization and sequestration of human m2 muscarinic acetylcholine receptors by autoantibodies from patients with Chagas' disease
50. Long-term carbachol treatment-induced down-regulation of muscarinic M2-receptors but not m2 receptor mRNA in a human lung cell line
51. Agonist-induced down-regulation of the m4 muscarinic acetylcholine receptor occurs without changes in receptor mRNA steady state levels
52. Agonist-mediated destabilization of m1 muscarinic acetylcholine receptor mRNA. Elements involved in mRNA stability are localized in the 3′-untranslated region
53. Regulation of muscarinic acetylcholine receptor mRNA expression by activation of homologous and heterologous receptors
54. Transregulation of adenylyl-cyclase-coupled inhibitory receptors in heart failure enhances anti-adrenergic effects on adult rat cardiomyocytes
55. i-proteins in heart failure
56. iα-2 in human end-stage heart failure
57. i during pacing-induced heart failure
58. 2 receptors of the adenylyl cyclase system
59. 2-muscarinic receptors in the human fight atrium
60. i proteins
61. Chronic treatment with carbachol sensitizes the myocardium to cAMP-induced arrhythmia
62. Transcriptional down-regulation of m2 muscarinic receptor gene expression in human embryonic lung (HEL 299) cells by protein kinase C
63. Analysis of muscarinic cholinoceptors mediating phosphoinositide hydrolysis in guinea pig cardiac muscle
64. Muscarinic receptor heterogeneity in neonatal rat ventricular myocytes in culture
65. 1 muscarinic acetylcholine receptors in rat ventricular myocytes
66. Does mammalian heart contain only the M2 muscarinic receptor subtype?
67. M1 muscarinic receptors increase calcium current and phosphoinositide turnover in guinea pig ventricular cardiocytes
68. Subtypes of muscarinic receptor on cholinergic nerves and atrial cells of chicken and guinea pig hearts
69. 2 muscarinic receptors
70. 2+ transients in guinea pig ventricular myocytes
71. Lack of effect of McN-A-343 on membrane current and contraction in guinea pig ventricular myocytes
72. + current
73. + current
74. Functional and molecular identification and characterization of cardiac M3 and M4 subtypes of muscarinic acetylcholine receptors (mAChRs)
75. Identification and characterization of multiple subtypes of muscarinic acetylcholine receptors and their physiological functions in canine hearts
76. Positive and negative inotropic effects of muscarinic receptor stimulation in mouse left atria
77. The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis: Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells
78. The porcine heart M2 receptor: Agonist-induced phosphorylation and comparison of properties with chick heart receptor
79. Radioligand binding characteristics of the chicken cardiac muscarinic receptor
80. Muscarinic cholinoceptors in the human heart: Demonstration, subclassification, and distribution
81. Different pharmacological responses of atrium and ventricle: Studies with human cardiac tissue
82. Characterization of the positive and negative inotropic effects of acetylcholine in the human myocardium
83. Age-dependent decrease in the negative inotropic effect of carbachol on isolated human right atrium
84. New functionally selective muscarinic agonists
85. Antiadrenergic effect of carbachol but not of adenosine on contractility in the intact human ventricle in vivo
86. Changes in myocardial and vascular receptors in heart failure
87. 2-, muscarinic receptor in the human heart?
88. Age-dependent changes in cardiac muscarinic receptor function in healthy volunteers
89. Possible mechanisms of anti-cholinergic drug-induced bradycardia
90. Dose-response curves of pirenzepine in man in relation to M1- and M2-cholinoceptor occupancy
91. 2-adrenergic receptor stimulation and the negative chronotropic effect of low-dose pirenzepine
92. Acetylcholine release in human heart atrium: Influence of muscarinic autoreceptors, diabetes and age
93. Inhibitory and excitatory muscarinic receptors modulating the release of acetylcholine from the postganglionic parasympthetic neuron of the chicken heart
94. Different muscarinic receptors mediate autoinhibition of acetylcholine release and vagally-induced vasoconstriction in the rat isolated perfused heart
95. A presynaptic excitatory M1 muscarine receptor at postganglionic cardiac noradrenergic nerve fibers that is activated by endogenous acetylcholine
96. Muscarinic M3 receptor subtype gene expression in the human heart
97. Regional and subcellular distribution of myocardial muscarinic cholinergic receptors
98. Muscarinic receptors and responses in intact embryonic chick atrial and ventricular heart cells
99. Comparison of muscarinic receptor properties in hatched chick heart atrium and ventricle
100. Cardiac muscarinic cholinergic receptors: Biochemical identification and characterization
101. Distribution of muscarinic acetylcholine receptors and presynaptic nerve terminals in amphibian heart
102. Muscarinic receptors in the failing human heart
103. Sympathetic-parasympathetic interactions in the heart
104. Promiscuous or heterogeneous muscarinic receptors in rat atria? I. Schild analysis with simple competetive antagonists
105. Effects of acetylcholine on the SA node of the heart
106. f
107. f, induced by acetylcholine in rabbit sino-atrial node myocytes
108. Direct activation of cardiac pacemaker channels by intracellular cyclic AMP
109. f, in rabbit sino-atrial node myocytes
110. Channel activity related to pacemaking
111. f, and cardiac pacemaking
112. f) is directly regulated by G-proteins
113. Heart rate regulation by G proteins acting on the cardiac pacemaker channel
114. Changes by acetylcholine of membrane currents in rabbit cardiac Purkinje fibers
115. Effects of acetylcholine on time-dependent currents in sheep cardiac Purkinje fibers
116. Modulation of the hyperpolarization-activated inward current (If) by antiarrhythmic agents in isolated human atrial myocytes
117. Hyperpolarization-activated inward current in ventricular myocytes from normal and failing human hearts
118. Zum mechanismus der membranwirkung des acetylcholin an der herzmuskelfaser
119. + channels in isolated pacemaker cells of the mammalian heart
120. Mode of regulation of the ACh-sensitive K-channel by the muscarinic receptor in atrial cells
121. Characterization of the acetylcholine-induced potassium current in rabbit cardiac Purkinje fibers
122. Isolated atrial myocytes: Adenosine and acetylcholine increase potassium conductance
123. + channels by adenosine in isolated atrial cells: Involvement of GTP-binding proteins
124. Attenuation of muscarinic cholinergic inhibition by islet-activating protein in the heart
125. GTP-binding proteins couple cardiac muscarinic receptors to a K channel
126. + channel in cardiac atrial cell membrane
127. + channel activation as revealed by hydrolysis-resistant GTP analogues
128. Desensitization of the acetylcholine-induced increase of potassium conductance in rabbit cardiac Purkinje fibers
129. The electrophysiological effects of acetylcholine in single human atrial cells
130. A photoisomerizable muscarinic antagonist
131. Rapid β-adrenergic modulation of cardiac calcium channel currents by a fast G protein pathway
132. iα-subunits
133. + channel
134. k
135. The α-subunit of the GTP binding protein activates muscarinic potassium channels of the atrium
136. The βγ subunits of GTP-binding proteins activate the muscarinic K channel in heart
137. + channel
138. 2
139. + channel
140. G protein control of cardiac potassium channels
141. Activation of the cloned muscarinic potassium channel by G protein βγ subunits
142. G protein regulation of potassium ion channels
143. K.ACh
144. Novel inhibition of Gβγ-activated potassium currents induced by M2 muscarinic receptors via a pertussis toxin-insensitive pathway
145. Comparison of effects of acetylcholine on calcium and potassium currents in frog atrium and ventricle
146. + channel in ferret ventricular myocytes
147. A direct negative inotropic effect of acetylcholine on rat ventricular myocytes
148. On the mechanism of muscarinic inhibition of the cardiac Ca current
149. Methylene blue is a muscarinic antagonist in cardiac myocytes
150. Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea pig trachea
151. The interaction between methylene blue and the cholinergic system
152. Three different potassium channels in human atrium. Contribution to the basal potassium conductance
153. + channels in mammalian ventricular myocytes
154. Activation of inwardly rectifying potassium channels by muscarinic receptor-linked G protein in isolated human ventricular myocytes
155. Functional role of cholinoceptors and purinoceptors in human isolated atrial and ventricular heart muscle
156. Ca-antagonistic effects of adenosine in guinea pig atrial cells
157. Membrane currents and their modification by acetylcholine in isolated single atrial cells of the guinea pig
158. Mechanism of action of acetylcholine on calcium current in single cells from frog ventricle
159. Calcium channel modulation by neurotransmitters, enzymes and drugs
160. Opposite effects of cyclic GMP and cyclic AMP on Ca current in single heart cells
161. Injection of guanosine 5′-cyclic monophosphate into heart cells blocks calcium slow channels
162. Role of phosphodiesterase in regulation of calcium current in isolated cardiac myocytes
163. Inhibition of cardiac slow action potentials by 8-bromo-cyclic GMP occurs independent of changes in cAMP levels
164. Cyclic GMP regulates the Ca-channel current in guinea pig ventricular myocytes
165. 2+ currents. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation
166. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes
167. Elevated cAMP suppresses muscarinic inhibition of L-type calcium current in guinea pig ventricular myocytes
168. Biphasic effects of intrapipette cyclic guanosine monophosphate on L-type calcium current and contraction of guinea pig ventricular myocytes
169. cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes
170. Nitric oxide and cardiac function
171. 2-cholinergic receptors in cultured rat ventricular myocytes
172. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system
173. An obligatory role for nitric oxide in autonomic control of mammalian heart rate
174. 2+ current in adult rabbit atrioventricular nodal cells
175. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes
176. Role of nitric oxide in parasympathetic modulation of β-adrenergic myocardial contractility in normal dogs
177. Ca.L is absent in mice with targeted disruption of endothelial nitric oxide synthase
178. Acute effects of nitric oxide and cyclic GMP on human myocardial contractility
179. Nitric oxide inhibits isoprenaline-induced positive inotropic effects in normal, but not in hypertrophied rat heart
180. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart
181. Nitric oxide inhibits the positive inotropic response to β-adrenergic stimulation in humans with left ventricular dysfunction
182. Increased sensitivity of nitric oxide synthase inhibition in patients with heart failure: Potentiation of β-adrenergic inotropic responsiveness
183. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure
184. Muscarinic and β-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase
185. ++-dependent constitutive nitric oxide synthase is not involved in the cyclic GMP-increasing effects of carbachol in ventricular cardiomyocytes
186. Nitric oxide has no chronotropic effect in right atria isolated from rat heart
187. 2+ current in human atrial myocytes
188. The ineffectiveness of NO-cyclic GMP signaling pathway in the atrial myocardium
189. Evidence against a role of nitric oxide in the indirect negative inotropic effect of M-cholinoceptor stimulation in human ventricular myocardium
190. G-Nitro-arginine methyl ester and other alkyl ester of arginine are muscarinic receptor antagonists
191. Cholinergic antagonism of beta-adrenergic stimulation of cardiac membrane protein phophorylation in situ
192. Effects of adenosine receptor and muscarinic cholinergic receptor agonists on cardiac protein phosphorylation: Influence of pertussis toxin
193. Studies on the phosphorylation of the inhibitory subunit of troponin during modification of contraction in perfused rat heart
194. ++-calmodulin-dependent mechanisms
195. Autonomic regulation of type I phosphatase in cardiac muscle
196. 2 and adenosine receptor agonists
197. Deferoxamine blocks interactions of fluoride and carbachol in isolated mammalian cardiac preparations
198. 2-specific muscarinic cholinergic receptor-mediated inhibition of cardiac regulatory protein phosphorylation
199. 2+ channels
200. Inotropic responses to DPI 201,106 in the failing human heart
201. 2+ signaling in mammalian atrial and ventricular myocardium
202. Physical factors in the analysis of the actions of drugs on myocardial contractility
203. On the negative inotropic effect in the cat's auricle
204. Interaction between cyclic adenosine monophosphate and cyclic guanosine monophosphate in guinea pig ventricular myocardium
205. Carbachol inhibits electrophysiological effects of cyclic AMP in ventricular myocytes
206. Correlation of cyclic AMP and cyclic GMP levels with changes in contractile force of dog ventricular myocardium during cholinergic antagonism of positive inotropic actions of histamine, glucagon, theophylline and papaverine
207. +-ion activity and force of contraction
208. + entry and augments Na/Ca exchange current in guinea pig ventricular myocytes
209. Cholinergic regulation of calcium sensitivity in cardiac muscle
210. Ventricular cholinergic receptor system: Interaction with adrenergic system
211. Negative and positive inotropic responses of the blood-perfused canine papillary muscle to acetylcholine
212. Parasympathetic control of the heart
213. 1 adenosine receptors and m-cholinoceptors in human myocardium
214. 1 adenosine receptors in human myocardium
215. A comparison between muscarinic receptor occupancy, adenylate cyclase inhibition, and inotropic response in human heart
216. iα in human hearts with dilated but not ischemic cardiomyopathy
217. Antiadrenergic effect of M-cholinoceptor stimulation on human ventricular contractility in vivo
218. Effects of intracoronary acetylcholine and atropine on basal and dobutamine-stimulated left ventricular contractility
219. Muscarinic receptor modulation of basal and β-adrenergic stimulated function of the failing human left ventricle
220. Influence of atropine on the cardiovascular effects of noradrenaline and tyramine in elder volunteers
221. Influence of adrenoceptor and muscarinic receptor blockade on the cardiovascular effects of exogenous noradrenaline and of endogenous noradrenaline released by infused tyramine
222. Autonomic regulation of delayed rectifier K current in mammalian heart involves G proteins
223. Mechanism of receptor-mediated modulation of the delayed outward potassium current in guinea pig ventricular myocytes
224. Muscarinic receptors mediate negative and positive inotropic effects in mammalian ventricular myocardium: Differentiation by agonists
225. Acetylcholine increases intracellular sodium activity in sheep Purkinje fibers
226. Sodium-dependent membrane current induced by carbachol in single guinea pig ventricular myocytes
227. Chloride conductance regulated by cyclic AMP-dependent protein kinase in cardiac myocytes
228. Isoproterenol activates a chloride current, not a transient outward current, in rabbit ventricular myocytes
229. Autonomic regulation of a chloride current in heart
230. Gap Junction channels in the cardiovascular system: Pharmacological and physiological modulation
231. Cardiac gap junctions: Three distinct channel conductances and their modulation by phosphorylating treatments
232. Inotropic agents modulate gap junctional conductance between cardiac myocytes
233. Single channel events and gating behaviour of the cardiac gap junctional channel
234. Regulation of cardiac gap junction channel permeability and conductance by several phosphorylating conditions
235. Gap junction formation and regulation in cultured adult rat and guinea pig cardiac muscle cells
236. Pertussis toxin-insensitive phosphoinositide hydrolysis, membrane depolarization and positive inotropic effect of carbachol in chick atria
237. i-like protein
238. Carbachol depolarizes and accelerates pacemaker activity in the sinoatrial node of chicks treated with pertussis toxin
239. Positive inotropic effects induced by carbachol in rat atria treated with islet-activating protein (IAP) - Association with phosphatidylinositol breakdown
240. Guanine nucleotide-dependent inositol trisphosphate formation in chick heart cells
241. Effects of carbachol and (-)-N6-phenylisopropyladenosine on myocardial inositol phosphate content and force of contraction
242. On the mechanism of muscarinic hydrolysis of choline phospholipids in the heart
243. 2+ concentration in rat ventricular myocytes
244. Effects of acetylcholine on the coronary artery
245. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries
246. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans
247. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis
248. Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries
249. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine-5-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta
250. Endothelium-mediated coronary blood flow modulation in humans: Effects of age, atherosclerosis, hypercholesterinemia, and hypertension
251. Characterization of muscarinic receptor subtype mediating contraction and relaxation in equine coronary artery in vitro
252. Muscarinic receptor subtypes mediating vasodilation and vasoconstriction in isolated, perfused simian coronary arteries
253. Characterization of muscarinic receptors mediating endothelium-dependent relaxation of bovine coronary artery
254. Studies on the characterization of the subtype(s) of muscarinic receptor involved in prostacyclin synthesis in rabbit cardiomyocytes
255. Release of endothelium-derived hyperpolarizing factor (EDHF) by M3 receptor stimulation in guinea-pig coronary artery
256. Characterization of muscarinic receptors of bovine coronary artery by functional and radioligand binding studies
257. Age related alteration in cholinergic but not α-adrenergic response of rat coronary artery vasculature
258. Muscarinic cholinergic receptors in the human fight coronary artery: A receptor binding and autoradiographic study
259. Cardiovascular regulatory mechanisms in advanced age
260. Alterations in β-adrenoceptor mechanisms in the aging heart: Relationship with heart failure
261. Age difference in the baroreceptor response of rats
262. Change in vagal activity and response to muscarinic receptor agonist with age
263. Alterations in cardiac parasympathetic function in aged rats
264. Enhanced chronotropic and inotropic responses of rat myocardium to cholinergic stimulus with aging
265. Effect of age on responsiveness of isolated rat atria to carbachol and on binding characteristics of atrial muscarinic receptors
266. Autonomic interactions in the aging heart: Age-associated decrease in muscarinic cholinergic receptor mediated inhibition of β-adrenergic activation of adenylate cyclase
267. Alterations in β-adrenergic and muscarinic receptors in aged rat heart: Effects of chronic administration of propranolol and atropine
268. Effects of age on muscarinic cholinergic receptors in rat myocardium
269. iα expression in senescence
270. β-adrenergic and muscarinic receptor expression are regulated in opposite ways during senescence in rat left ventricle
271. Differential changes of autonomic nervous system function with age in man
272. Heart rate variability in healthy subjects: Effect of age and the derivation of normal ranges for tests of autonomic function
273. Cardiac muscarinic receptors decrease with age: In vitro and in vivo studies
274. Action of atropine on the cardiovascular system in normal persons
275. Effects of atropine on the electrocardiogram in different age groups
276. Screening of serum autoantibodies to cardiac beta1-adrenoceptors and M2-muscarinic acetylcholine receptors in 408 healthy subjects of varying ages
277. Defective cardiac parasympathetic control in patients with heart disease
278. Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations
279. Scopolamine improves autonomic balance in advanced congestive heart failure
280. Anti-M2 muscarinic receptor autoantibodies and idiopathic dilated cardiomyopathy
281. Beta adrenoceptors and m-cholinoceptors in myocardium of hearts with coronary artery disease or idiopathic dilated cardiomyopathy removed at cardiac transplantation
282. Receptor systems affecting force of contraction in the human heart and their alterations in chronic heart failure
283. Increase in functional activity rather than in amount of Gi-α in failing human heart with dilated cardiomyopathy
284. Endothelin receptors in the failing and non-failing human heart
285. Cardiac beta-adrenoceptors in chronic uremia: Studies in humans and rats
286. Increased myocardial muscarinic receptor density in idiopathic dilated cardiomyopathy. An in vivo PET study
287. + channel response to acetylcholine and to G protein-mediated activation in atrial myocytes isolated from failing human hearts
288. Adrenergic and muscarinic receptor regulation and therapeutic implications in heart failure
289. G proteins and the heart
290. Reduced muscarinic cholinoceptor density and sensitivity in various models of experimental cardiac hypertrophy
291. Impaired cardiac muscarinic receptor function in dogs with heart failure
292. Changes in cardiac signal transduction systems in chronic ethanol treatment preceding the development of alcoholic cardiomyopathy
293. 2-muscarinic receptors increase in canine pacing-overdrive model of heart failure
294. i protein mediated muscarinic receptor adenylyl cyclase in chronic ischaemic heart failure in the rat
295. The cardiac β-adrenoceptor-G-protein(s)-adenylylcyclase system in monocrotaline-treated rats
296. iα proteins increases arrhythmogenic effects of β-adrenergic stimulation in the heart
297. Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice
298. M(2) and M(4) receptor knockout mice: Muscarinic receptor function in cardiac and smooth muscle in vitro
299. Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function
300. Myocardial hypertrophy in transgenic mice overexpressing the bovine growth hormone (bGH) gene
301. Disruption of the ml receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice
302. 1 receptors
303. 3 subtype
304. 4 muscarinic acetylcholine receptor knockout mice
305. Receptor and ion channel nomenclature supplement
306. Muscarinic acetylcholine receptors: The IUPHAR-compendium of receptor characterization and classification
307. The muscarinic M(5) receptor: A silent or emerging subtype?
308. Toxins from mamba venoms: Small proteins with selectivities for different subtypes of muscarinic acetylcholine receptors